Okadaic acid enhances prostaglandin E1-induced alkaline phosphatase activity in osteoblast-like cells: Regulation at a point downstream from protein kinase A

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 55, Issue 5, 1996, Pages 357-361

  Ito, Y ^a   Suzuki, A ^a   Watanabe Tomita, Y ^a   Oiso, Y ^a   Kozawa, O ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BUCLADESINE; CYCLIC AMP; INOSITOL PHOSPHATE; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROSTAGLANDIN E1; TAUTOMYCIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL;

EID: 0029905031     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90042-3     Document Type: Article

References (28)

1. Peck W. A., Birge S. J. Jr., Fedak S. A. Bone cells: Biochemical and biological studies after enzymatic isolation. Science 1964; 146: 1476-1477.
2. Stein G. S., Lian J. B., Owen T. A. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 1990; 4: 3111-3123.
3. 2, parathyroid hormone, 1,25 dihydroxycholecalciferol, and cyclic nucleotide analogs on alkaline phosphatase activity in osteoblastic cells. Calcif Tissue Int 1984; 36: 72-76.
4. Kodama H., Amagai Y., Sudo H., Kasai S., Yamamoto S. Establishment of a clonal osteoblastic cell line from newborn mouse calvaria. Jpn J Oral Biol 1981; 23: 899-901.
5. Sudo H., Kodama H., Amagai Y., Yamamoto S., Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 1983; 96: 191-198.
6. Miwa M., Kozawa O., Tokuda H. et al. Effects of hypergravity on proliferation and differentiation of osteoblast-like cells. Bone Miner 1991; 14: 15-25.
7. Kotoyori J., Tokuda H., Suzuki A., Oiso Y., Kozawa O. Pertussis toxin enhances fetal calf serum-induced alkaline phosphatase activity in osteoblast-like cells. Harm Metab Res 1994; 26: 116-118.
8. Kozawa O., Takatsuki K., Kotake K, Yoneda M., Oiso Y., Saito H. Possible involvement of protein kinase C in proliferation and differentiation of osteoblast-like cells. FEBS Lett 1989; 243: 183-185.
9. Cohen P., Holmes C. F. B., Tsukitani Y. Okadaic acid: a new probe for the of cellular regulation. Trends Biochem Sci 1990; 15: 98-102.
10. Suganuma M., Fujiki H., Suguri H. et al. Okadaic acid: An additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proc Natl Acad Sci USA 1988; 85: 1768-1771.
11. Feyen J. H. M., Kuntzelmann G. M. M. Inhibitory effect of okadaic acid on bone resorption in neonatal mouse calvaria in vitro. Biochem Biophys Res Commun 1991; 178: 758-763.
12. Goad D. L., Meurer E. A., Voelkel E. F., Petrou C. P., Tashjian A. H. Jr. Protein phosphatase inhibitors and bone resorption: inhibition by okadaic acid and biphasic actions of calyculin-A. Endocrinology 1992; 130: 3402-3410.
13. Watanabe Y., Kozawa O., Suzuki A., Kotoyori J., Ito Y., Oiso Y. Okadaic acid reverses the inhibitory effect of protein kinase C on alkaline phosphatase activity in osteoblast-like cells. Mol Cell Endocrinol 1994; 103: 115-118.
14. Nijweide P. J., Burger E. H., Feyen J. H. M. Cells of bone: proliferation, differentiation and hormonal regulation. Physiol Rev 1986; 66: 855-886.
15. 2α stimulate differentiation and proliferation, respectively, of clonal osteoblastic MC3T3-E1 cells by different second messengers in vitro. Endocrinology 1987; 121: 1966-1974.
16. Lowry O. H., Roberts N. R., Wu M. L., Hixon W. S., Crawford E.J. The quantitative histochemistry of brain. II. Enzyme measurements. J Biol Chem 1954; 207: 19-37.
17. Herrmann-Erlee M. P. M., Nijweide P. J., van der Meer J. M., Ooms M. A. C. Action of bPTH and bPTH fragments on embryonic bone in vitro: dissociation of the cyclic AMP and bone resorbing response. Calcif Tissue Int 1983; 35: 70-77.
18. Honma M., Sato T., Takezawa J., Ui M. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue. Biochem Med 1977; 18: 257-273.
19. 2-stimulated phospholipase D in osteoblast-like cells: possible involvement of PKC. Am J Physiol 1995; 269: E524-E529.
20. Nishiwaki S., Fujiki H., Suganuma M. et al. Structure-activity relationship within a series of okadaic acid derivatives. Carcinogenesis 1990; 11: 1837-1841.
21. MacKintosh C., Klumpp S. Tautomycin from the bacterium Streptomyces verticillatus. Another potent and specific inhibitor of protein phosphatases 1 and 2A. FEBS Lett 1990; 277: 137-140.
22. Nishizuka Y. Studies and perspectives of protein kinase C. Science 1986; 233: 305-312.
23. Exton J. H. Signaling through phosphatidylcholine breakdown. J Biol Chem 1990; 265: 1-4.
24. Billah M. M., Anthes J. C. The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem J 1990; 269: 281-291.
25. 2 on phospholipase D activity in osteoblast-like MC3T3-E1 cells. J Bone Miner Res 1995; 10: 1185-1190.
26. Mumby M. C., Walter G. Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol Rev 1993; 73: 673-699.
27. Fujiki H., Suganuma M. Tumor promotion by inhibitors of protein phosphatases 1 and 2A. Adv Cancer Res 1993; 61: 143-194.
28. Kovacs C. S., Chik C. L, Li B., Karpinski E., Ho A. K. Inhibition of serine/threonine protein phosphatases enhances agonist-stimulated cAMP accumulation in UMR 106 osteoblast-like cells. Mol Cell Endocrinol 1995; 110: 9-16.